Skip to main content
Log in

Characteristics of surgically transposed ovaries on 18F-FDG PET/CT among patients with cancer

  • Original Article
  • Published:
Annals of Nuclear Medicine Aims and scope Submit manuscript

Abstract

Objective

Fertility preservation in women with cancer is important for improving their quality of life. Successful ovarian transposition protects the ovary from radiation and preserves ovarian endocrine function and fertility. With the increasing use of 18F-FDG PET/CT in gynecologic malignancies, the findings of transposed ovaries sometimes vary. This study aimed to characterize the 18F-FDG PET/CT findings of surgically transposed ovaries among a large number of patients with various medical conditions.

Methods

We retrospectively reviewed the medical records, including surgical history, and analyzed the findings of the transposed ovaries of patients who underwent ovarian transposition. Quantitative analysis was performed, and the maximum standardized uptake values (SUVs) were recorded. The Hounsfield unit (HU) and size (measured using the long diameter on the axial image) of the transposed ovary were evaluated.

Results

No significant change was found in the SUV of the transposed ovaries in relation to age and time after surgery. In two cases in which metastasis occurred in the transposed ovary, the lesions showed higher SUVs and HUs than did the other non-metastatic transposed ovaries. In several serial follow-up cases, varying 18F-FDG uptake was observed.

Conclusion

The 18F-FDG uptake pattern of the transposed ovary did not differ from that of the normal ovary. Misinterpretation should be avoided by considering surgical records, presence of surgical clips, and patients’ disease state. If there is a high uptake in the transposed ovary, it is necessary to check for soft tissue lesions and differentiate metastasis from the physiologic uptake.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

  1. Angarita AM, Johnson CA, Fader AN, Christianson MS. Fertility preservation: a key survivorship issue for young women with cancer. Front Oncol. 2016;6:102.

    Article  Google Scholar 

  2. Letourneau JM, Ebbel EE, Katz PP, Katz A, Ai WZ, Chien AJ, et al. Pretreatment fertility counseling and fertility preservation improve quality of life in reproductive age women with cancer. Cancer. 2012;118:1710–7.

    Article  Google Scholar 

  3. Donnez J, Dolmans MM. Fertility preservation in women. N Engl J Med. 2018;378:400–1.

    PubMed  Google Scholar 

  4. Wallace WH, Anderson RA, Irvine DS. Fertility preservation for young patients with cancer: who is at risk and what can be offered? Lancet Oncol. 2005;6:209–18.

    Article  Google Scholar 

  5. Wallace WH, Thomson AB, Kelsey TW. The radiosensitivity of the human oocyte. Hum Reprod. 2003;18:117–21.

    Article  CAS  Google Scholar 

  6. De Vos M, Smitz J, Woodruff TK. Fertility preservation in women with cancer. Lancet. 2014;384:1302–10.

    Article  Google Scholar 

  7. Dursun P, Ayhan A, Yanik FB, Kuşçu E. Ovarian transposition for the preservation of ovarian function in young patients with cervical carcinoma. Eur J Gynaecol Oncol. 2009;30:13–5.

    CAS  PubMed  Google Scholar 

  8. Morice P, Juncker L, Rey A, El-Hassan J, Haie-Meder C, Castaigne D. Ovarian transposition for patients with cervical carcinoma treated by radiosurgical combination. Fertil Steril. 2000;74:743–8.

    Article  CAS  Google Scholar 

  9. Narayanan P, Sahdev A. The role of (18)F-FDG PET CT in common gynaecological malignancies. Br J Radiol. 2017;90:20170283.

    Article  Google Scholar 

  10. Rockall AG, Cross S, Flanagan S, Moore E, Avril N. The role of FDG-PET/CT in gynaecological cancers. Cancer Imaging. 2012;12:49–65.

    Article  Google Scholar 

  11. Akin EA, Kuhl ES, Zeman RK. The role of FDG-PET/CT in gynecologic imaging: an updated guide to interpretation and challenges. Abdom Radiol (NY). 2018;43:2474–86.

    Article  Google Scholar 

  12. Liu Y. Benign ovarian and endometrial uptake on FDG PET-CT: patterns and pitfalls. Ann Nucl Med. 2009;23:107–12.

    Article  CAS  Google Scholar 

  13. Nishizawa S, Inubushi M, Okada H. Physiological 18F-FDG uptake in the ovaries and uterus of healthy female volunteers. Eur J Nucl Med Mol Imaging. 2005;32:549–56.

    Article  Google Scholar 

  14. Lerman H, Metser U, Grisaru D, Fishman A, Lievshitz G, Even-Sapir E. Normal and abnormal 18F-FDG endometrial and ovarian uptake in pre- and postmenopausal patients: assessment by PET/CT. J Nucl Med. 2004;45:266–71.

    PubMed  Google Scholar 

  15. Chung HH, Kang WJ, Kim JW, Park NH, Song YS, Chung JK, et al. Characterization of surgically transposed ovaries in integrated PET/CT scan in patients with cervical cancer. Acta Obstet Gynecol Scand. 2007;86:88–93.

    Article  Google Scholar 

  16. Zissin R, Metser U, Lerman H, Lievshitz G, Safra T, Even-Sapir E. PET-CT findings in surgically transposed ovaries. Br J Radiol. 2006;79:110–5.

    Article  CAS  Google Scholar 

  17. Davidson T, Komisar O, Korach J, Felder S, Apter S, Ben-Haim S, et al. Physiologic uptake of 18F-FDG in transposed ovaries may mimic metastasis on 18F-FDG PET/CT imaging. Nucl Med Commun. 2018;39:171–8.

    Article  Google Scholar 

  18. Agrawal K, Sajjan RS, Saad ZZ, Groves A, Bomanji J, Syed R. Transposed ovary mimicking a peritoneal implant on FDG PET/CT in a patient with carcinoma of the rectum. Eur J Nucl Med Mol Imaging. 2014;41:1642–3.

    Article  Google Scholar 

  19. Morice P, Haie-Meder C, Pautier P, Lhomme C, Castaigne D. Ovarian metastasis on transposed ovary in patients treated for squamous cell carcinoma of the uterine cervix: report of two cases and surgical implications. Gynecol Oncol. 2001;83:605–7.

    Article  CAS  Google Scholar 

  20. Janse JA, Sie-Go DM, Schreuder HW. Ovarian metastasis in a transposed ovary 10 years after primary cervical cancer: the importance of histologic examination and review of literature. BMJ Case Rep. 2011;2011:0420114155.

    Article  Google Scholar 

  21. Chambers SK, Chambers JT, Kier R, Peschel RE. Sequelae of lateral ovarian transposition in irradiated cervical cancer patients. Int J Radiat Oncol Biol Phys. 1991;20:1305–8.

    Article  CAS  Google Scholar 

  22. Feeney DD, Moore DH, Look KY, Stehman FB, Sutton GP. The fate of the ovaries after radical hysterectomy and ovarian transposition. Gynecol Oncol. 1995;56:3–7.

    Article  CAS  Google Scholar 

  23. Pahisa J, Martínez-Román S, Martínez-Zamora MA, Torné A, Caparrós X, Sanjuán A, et al. Laparoscopic ovarian transposition in patients with early cervical cancer. Int J Gynecol Cancer. 2008;18:584–9.

    Article  CAS  Google Scholar 

  24. Hoekman EJ, Knoester D, Peters AAW, Jansen FW, de Kroon CD, Hilders C. Ovarian survival after pelvic radiation: transposition until the age of 35 years. Arch Gynecol Obstet. 2018;298:1001–7.

    Article  Google Scholar 

  25. Lee P, Greenfield JR, Ho KK, Fulham MJ. A critical appraisal of the prevalence and metabolic significance of brown adipose tissue in adult humans. Am J Physiol Endocrinol Metab. 2010;299:E601–6.

    Article  CAS  Google Scholar 

  26. Cronin CG, Prakash P, Daniels GH, Boland GW, Kalra MK, Halpern EF, et al. Brown fat at PET/CT: correlation with patient characteristics. Radiology. 2012;263:836–42.

    Article  Google Scholar 

  27. Steinberg JD, Vogel W, Vegt E. Factors influencing brown fat activation in FDG PET/CT: a retrospective analysis of 15,000+ cases. Br J Radiol. 2017;90:20170093.

    Article  Google Scholar 

  28. Brendle C, Werner MK, Schmadl M, la Fougère C, Nikolaou K, Stefan N, et al. Correlation of brown adipose tissue with other body fat compartments and patient characteristics: a retrospective analysis in a large patient cohort using PET/CT. Acad Radiol. 2018;25:102–10.

    Article  Google Scholar 

Download references

Acknowledgements

This work was supported by the National Research Foundation of Korea (NRF) Grant funded by the Korea government (MSIT) (No. 2020M2D9A1093991).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Won Jun Kang.

Ethics declarations

Conflict of interest

There is no conflict of interest.

Ethical approval

Ethical approval was obtained from Severance Hospital Institutional Review Board (Approval number: 4-2020-1085).

Informed consent

The need of informed consent was waived by the IRB committee.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Jo, K.H., Kim, S., Hwang, S.H. et al. Characteristics of surgically transposed ovaries on 18F-FDG PET/CT among patients with cancer. Ann Nucl Med 35, 1100–1108 (2021). https://doi.org/10.1007/s12149-021-01645-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12149-021-01645-0

Keywords

Navigation